Preclinical studies have indicated that pegsunercept, a polyethylene-glycol-modified soluble tumor-necrosis-factor receptor type 1, is effective in treating rheumatoid arthritis (RA). Pegsunercept ...
placebo controlled trial on glucocorticoids in very early arthritis. Ann. Rheum. Dis. (in press). Kirwan, J. R. The effects of glucocorticoids on joint destruction in rheumatoid arthritis.